Navigation Links
Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
Date:9/9/2012

AUSTIN, Texas, Sept. 10, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX), today announced that it will host Planet xMAP Europe 2012, its annual European multiplexing technology symposium, October 10-11, 2012 at the Grimaldi Forum in the Principality of Monaco.  Luminex anticipates attendance of over 500 scientists and more than 40 scientific presentations to be addressed during the 10th anniversary event. The two-day program features scientific sessions, workshops, discussion groups, exhibitions and networking events with scientists and researchers from around the world who are performing groundbreaking work in clinical diagnostics and life science research using Luminex's technology platforms.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO )

"We are excited to have scientists from around the world share their latest research and to see the continued growth in new applications for multiplexing technology," said Paul C. Ladestein, General Manager European Operations for Luminex. "The focus this year is on new developments in the areas of newborn screening, infectious disease, immunology-monitoring, human genetics, protein and nucleic acid research.  Planet xMAP Europe is always an excellent opportunity for leading scientists to gather and exchange ideas on how xMAP multiplexing technology is revolutionizing their laboratories and research.  Our 10th anniversary event highlights the contributions our technology is making in advancing research and healthcare around the globe."

Planet xMAP Europe 2012 will feature two days of presentations with keynote lectures from:

  • Dr. Jean William Pape, Director and Founder of GHESKIO Centers (Haitian Study Group on Kaposi's sarcoma and Opportunistic Infections) Haiti, Professor of Medicine at Weill Medical College of Cornell University in New York
  • Dr. Freda Miller, Cell and molecular developmental neurobiologist at the Hospital for Sick Children Research Institute, Professor at University of Toronto, Canada
  • Day One of Planet xMAP Europe 2012, Wednesday, 10 October, will focus on Pathogen Detection, Gastrointestinal Infections, Respiratory Viral Infections, and Newborn ScreeningThe morning session will include the following presentations:

    30 years experience in the fight against infectious diseases in Haiti 
    Dr. Jean William Pape, GHESKIO Centers,Weill Medical College of Cornell University, Haiti
    Abstract

    Multiplex Diagnosis Reveals New Challenges for Malaria Elimination 
    Dr. Peter A. Zimmerman, Case Western University, Cleveland, Ohio
    Abstract 

    Rational multiplex serological screening system for common pathogens using suspension arrays 
    Dr. Jonas Blomberg, Clinical Microbiology, Academic Hospital, Uppsala, Sweden
    Abstract

    Preliminary findings of a Health Economic Study of the Luminex xTAG® Gastrointestinal Pathogen Panel at Guy's & St. Thomas' NHS trust 2011-12
    Dr. Eugene Halligan, Guy's & St. Thomas' Hospital, London, UK
    Abstract

    Newborn Screening: Current Situation and Future Applications 
    Dr. David C. Kasper, Medical University of Vienna, Vienna, Austria
    Abstract

    The afternoon session will feature three separate tracks focused on Human Genetics, Immunology-Monitoring, and Pathogen Detection.

    Day Two of Planet xMAP Europe 2012, Thursday, 11 October, will focus on Neural Stem Cells, Tumor Microenvironment, the Immune-Proteome, and Cellular SystemsThe morning session will include the following presentations:

    Neural stem cells: from development to repair 
    Dr. Freda Miller, Hospital for Sick Children Research Institute
    Abstract

    Chronic inflammatory and immunosuppressive conditions in tumor microenvironment and their neutralization
    Dr. Viktor Umansky, German Cancer Research Center, Heidelberg and University Hospital Mannheim, Germany
    Abstract

    Systematic high-throughput / high content analysis of the immune-proteome using Luminex-based multiplex arrays
    Dr. Peter Schulz-Knappe, Protagen AG, Dortmund, Germany
    Abstract

    Capturing the Complexity of Cellular Systems 
    Dr. John K. Westwick, Odyssey Thera, Inc., San Ramon, California
    Abstract 

    The afternoon session will feature two separate tracks focused on Genomic and Protein Research.

    For detailed information regarding the Planet xMAP Europe 2012 symposium and agenda, or to register online, please visit http://www.planetxmap.com .

    About Luminex CorporationLuminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform, MultiCode® real-time polymerase chain reaction (PCR), and multiplex PCR-based technologies, that deliver cost-effective rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, biodefense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com .Contacts Corporate:

    Media: Harriss T. Currie

    Mimi TorringtonChief Financial Officer and Vice President, Finance

    Director, Marketing CommunicationsLuminex Corporation

    Luminex Corporation hcurrie@luminexcorp.com  

    mtorrington@luminexcorp.com   +1.512.219.8020

    +1.512.219.8020 Investors:

    Aaron DeLucia:Matthew Scalo

    Porter NovelliSr. Director, Investor Relations

    Aaron.DeLucia@porternovelli.com  Luminex Corporation

    +1.512.241.2249mscalo@luminexcorp.com +1.512.219.8020 

     

     


    '/>"/>
    SOURCE Luminex Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Luminex Corporation Recognized as Best Technology Company in Austin
    2. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
    3. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
    4. Luminex Corporation Reports Second Quarter 2012 Results
    5. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
    6. Luminex Corporation Announces Agreement to Acquire GenturaDx
    7. Luminex Corporation Reports First Quarter 2012 Results
    8. Faruqi & Faruqi, LLP is Investigating AmerisourceBergen Corporation on Behalf of its Shareholders
    9. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
    10. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
    11. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
    (Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
    (Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
    Breaking Medicine Technology:
    (Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
    (Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
    (Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
    (Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
    (Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
    Breaking Medicine News(10 mins):